As of 2026-03-27, the EV/EBITDA ratio of Treace Medical Concepts Inc (TMCI) is -2.96. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. TMCI's latest enterprise value is 127.55 mil USD. TMCI's TTM EBITDA according to its financial statements is -43.10 mil USD. Dividing these 2 quantities gives us the above TMCI EV/EBITDA ratio.
Note: valuation result may not be accurate due to the company's negative EBITDA.
| Range | Selected | |
| Trailing P/E multiples | 15.3x - 19.0x | 17.2x |
| Forward P/E multiples | 19.3x - 22.4x | 21.8x |
| Fair Price | (13.60) - (13.39) | (13.69) |
| Upside | -1162.5% - -1145.8% | -1169.5% |
| Date | EV/EBITDA |
| 2026-03-23 | -2.93 |
| 2026-03-20 | -2.90 |
| 2026-03-19 | -3.00 |
| 2026-03-18 | -3.06 |
| 2026-03-17 | -3.23 |
| 2026-03-16 | -3.17 |
| 2026-03-13 | -3.23 |
| 2026-03-12 | -3.06 |
| 2026-03-11 | -3.12 |
| 2026-03-10 | -3.26 |
| 2026-03-09 | -3.51 |
| 2026-03-06 | -3.18 |
| 2026-03-05 | -3.12 |
| 2026-03-04 | -3.24 |
| 2026-03-03 | -3.39 |
| 2026-03-02 | -3.53 |
| 2026-02-27 | -3.83 |
| 2026-02-26 | -4.19 |
| 2026-02-25 | -4.10 |
| 2026-02-24 | -3.99 |
| 2026-02-23 | -4.05 |
| 2026-02-20 | -3.87 |
| 2026-02-19 | -3.92 |
| 2026-02-18 | -3.81 |
| 2026-02-17 | -3.78 |
| 2026-02-13 | -3.83 |
| 2026-02-12 | -3.89 |
| 2026-02-11 | -4.07 |
| 2026-02-10 | -4.17 |
| 2026-02-09 | -4.35 |
| 2026-02-06 | -4.43 |
| 2026-02-05 | -4.10 |
| 2026-02-04 | -4.22 |
| 2026-02-03 | -4.17 |
| 2026-02-02 | -4.43 |
| 2026-01-30 | -4.52 |
| 2026-01-29 | -4.49 |
| 2026-01-28 | -4.64 |
| 2026-01-27 | -4.85 |
| 2026-01-26 | -4.79 |
| 2026-01-23 | -4.91 |
| 2026-01-22 | -5.07 |
| 2026-01-21 | -4.95 |
| 2026-01-20 | -4.94 |
| 2026-01-16 | -5.00 |
| 2026-01-15 | -5.01 |
| 2026-01-14 | -5.09 |
| 2026-01-13 | -5.10 |
| 2026-01-12 | -5.24 |
| 2026-01-09 | -5.39 |